Kristopher Hanson, General Counsel of MapLight Therapeutics, Inc. (NASDAQ:MPLT), filed a Form 4 on September 18, 2026, disclosing the sale of 16,509 shares of Voting Common Stock on September 16, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Shares sold: Kristopher Hanson disposed of 16,509 shares of Voting Common Stock on September 16, 2026.
  • Weighted average price: The reported sale price was $11.67, a weighted average across multiple transactions ranging from $11.38 to $12.17 inclusive.
  • Remaining ownership: Following the transaction, Hanson directly owns 137,044 shares of Voting Common Stock.
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted by Hanson on December 29, 2025.
  • Reporting person's role: Hanson is identified in the filing as General Counsel of MapLight Therapeutics, Inc.

Hanson's Rule 10b5-1 Sale of MapLight Therapeutics Shares

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Kristopher Hanson, General Counsel of MapLight Therapeutics, Inc., sold 16,509 shares of the company's Voting Common Stock on September 16, 2026. The filing indicates the transaction was executed under a Rule 10b5-1 trading plan that Hanson adopted on December 29, 2025, and the form's checkbox confirms it was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

The filing reports the sale price as a weighted average of $11.67 per share. The shares were sold in multiple transactions at prices ranging from $11.38 to $12.17 inclusive, according to the footnote. The filing further states that Hanson "undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."

Following the reported disposition, Hanson directly beneficially owns 137,044 shares of Voting Common Stock, as disclosed in Table I of the filing. No derivative securities transactions were reported in Table II.

What Was Disclosed

MapLight Therapeutics General Counsel Kristopher Hanson reported a sale of 16,509 shares of Voting Common Stock on September 16, 2026, at a weighted average price of $11.67, leaving him with direct ownership of 137,044 shares. The sale occurred under a pre-scheduled 10b5-1 plan.